Skip to search formSkip to main contentSkip to account menu

ramosetron

Known as: 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazol 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

AntiemeticsBenzimidazolesSerotonin Antagonists

Narrower (2)

NaseaYM 060
ramosetron hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta…
2016
2016
5‐HT3 receptors promote colonic inflammation via activation of substance P/neurokinin‐1 receptors in dextran sulphate sodium‐induced murine colitis
5‐HT (serotonin) regulates various physiological functions, both directly and via enteric neurons. The present study investigated… 
Review
2011
Review
2011
Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.
  • R. Spiller
  • Current opinion in pharmacology (Print)
  • 2011
  • Corpus ID: 28268571
Highly Cited
2010
Highly Cited
2010
Prophylactic control of post‐operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery
Background: The aim of this study was to evaluate the efficacy of ondansetron and ramosetron in the reduction of post‐operative… 
Highly Cited
2009
Highly Cited
2009
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
BACKGROUND Ramosetron is a new selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonist that reportedly has more potent… 
Highly Cited
2008
Highly Cited
2008
Effect of Ramosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Spine Surgery in Highly Susceptible Patients: Comparison With Ondansetron
Study Design. A prospective, randomized, double-blind clinical trial. Objective. To compare the effect of ramosetron with that of… 
Review
2002
Review
2002
Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.
Ramosetron is a selective serotonin 5-HT3 receptor antagonist with an affinity higher than that of the previously available drugs… 
Highly Cited
2000
Highly Cited
2000
Ramosetron for Preventing Postoperative Nausea and Vomiting in Women Undergoing Gynecological Surgery
In a prospective, randomized, double-blinded, placebo-controlled trial, we evaluated the efficacy of ramosetron at three… 
Highly Cited
1999
Highly Cited
1999
Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery.
UNLABELLED In a prospective, randomized, double-blinded study, we evaluated the efficacy of granisetron and ramosetron for… 
Highly Cited
1996
Highly Cited
1996
Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)